Benjamin Spurgeon: What’s next for Platelet Function Testing?
Benjamin Spurgeon, Associate Director of Diagnostic Hematology Versiti Inc, shared a post on LinkedIn about his a recent article published in RPTH, adding:
“What’s next for Platelet Function Testing?
For too long, patients with bleeding disorders, particularly those who are thrombocytopenic, pediatric, or in remote areas, have had limited access to reliable platelet function testing.
Flow cytometry is helping to expand those possibilities.
By allowing sensitive analysis of platelets in whole blood with small sample volumes, it offers a way to broaden access to advanced testing and explore new insights into platelet function.
Building on my remarks in Washington, D.C., this article in RPTH Journal explores where platelet flow cytometry may be headed.
I consider:
- Why a focused panel of validated markers may provide the greatest clinical relevance
- The potential for scalable, more widely accessible platelet testing”
Title: Markers for platelet function testing by flow cytometry: where are we now? A clinical perspective
Authors: Benjamin E.J. Spurgeon

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 13, 2026, 20:28Tarun Tyagi: Translational Insights into Severe Immune Thrombocytopenia
-
Jun 13, 2026, 18:25Miguel Gómez Álvarez: Reviewing Inflammation, Transplantation, and Gene Therapy in Hemoglobinopathies
-
Jun 13, 2026, 18:24Ana Pedrero Gil: Why Factor XIII Deficiency Is Often Overlooked During Acute Bleeding
-
Jun 13, 2026, 18:23Tobias Degsell: Building Stronger Bridges Across Disciplines, Countries, and Perspectives at EHA 2026
-
Jun 13, 2026, 18:22Haemoglobinopathies, Innovation, Patient Experience, and Equitable Access at EHA 2026 – TIF
-
Jun 13, 2026, 18:21Thomas Stauch: Discussing the Future of ITP Research and Patient Care
-
Jun 13, 2026, 17:11Kim De Keersmaecker: Advancing Hematology Through Shared Expertise at EHA 2026
-
Jun 13, 2026, 17:03Nour Al-Mozain: The Evolving Role of Apheresis Across Clinical Practice
-
Jun 13, 2026, 16:45Sarah Hendry: A Big Day for Gene Therapy Research at EHA 2026